RIMA M SALIBA to Infliximab
This is a "connection" page, showing publications RIMA M SALIBA has written about Infliximab.
Connection Strength
0.125
-
Prognostic value of response after upfront therapy for acute GVHD. Bone Marrow Transplant. 2012 Jan; 47(1):125-31.
Score: 0.090
-
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant. 2009 Dec; 15(12):1555-62.
Score: 0.020
-
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood. 2004 Aug 01; 104(3):649-54.
Score: 0.014